{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T08:39:07.846950+00:00","company":{"ticker":"RGBP","cik":1589150,"company_name":"Regen BioPharma Inc"},"pagination":{"limit":100,"returned":1,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"auditor_change","fact_key":"aa058c3126f15b70a7be6caa757b3a026720377e","cik":1589150,"ticker":"RGBP","company_name":"Regen BioPharma Inc","filed_at":"2024-05-10T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"BF Borgers CPA PC","disagreement_text":null,"effective_date":"2024-05-10","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Regen BioPharma Inc dismissed BF Borgers CPA PC as its auditor.","evidence_excerpt":"On May 10, 2024 the Board of Directors of Regen Biopharma, Inc. (the “Company”) approved the dismissal; of BF Borgers CPA PC as the Company’s independent registered public accounting firm, effective immediately","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001607062-24-000175","anchor_url":"https://secwatch.observer/filing/0001607062-24-000175#claim-aa058c3126f15b70a7be6caa757b3a026720377e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1589150/000160706224000175/0001607062-24-000175-index.htm"}]}